Select acadia healthcare hospitals to participate in clinical trial for acute suicidal ideation and behavior in major depression drug

Franklin, tenn.--(business wire)---- $achc--acadia healthcare company, inc. (nasdaq: achc) today announced that select facilities from its network of acute care behavioral health hospitals will participate in a registration directed trial to study participants with suicidal ideation and behavior with major depression. this study is sponsored by seelos therapeutics (nasdaq: seel) for its sls-002 investigational drug. acadia hospitals that meet the criteria for participation as clinical trial sites will be
SEEL Ratings Summary
SEEL Quant Ranking